Patents Assigned to MURDOCK TECHNOLOGIES, LLC
  • Method to deliver antifibrinolytic drugs to mitigate damage to the brain caused by concussive impact
    Patent number: 11576882
    Abstract: Antifibrinolytic agents/drugs are applied to the concussive area of a patient's brain to counter the activation of a fibrinolytic process in the concussive area. Various techniques are described for administering the antifibrinolytic agent.
    Type: Grant
    Filed: November 1, 2016
    Date of Patent: February 14, 2023
    Assignee: Murdock Technologies, LLC
    Inventor: Frank Murdock
  • Methods to deliver antifibrinolytic drugs for anti-aging results
    Patent number: 10792232
    Abstract: Antifibrinolytic agents are administered to a human individual to treat fine lines, wrinkles and overall skin tone of the face and body, as well as inflammation and tissue degradation effects.
    Type: Grant
    Filed: October 17, 2017
    Date of Patent: October 6, 2020
    Assignee: MURDOCK TECHNOLOGIES, LLC
    Inventor: Frank Murdock